Caplight Directory>Companies>Mitera Biosciences-preview>Miterabio


Mitera Biosciences

Mitera Biosciences

Private
Bellevue, WashingtonN/Ahttps://www.miterabio.com/

Last Round

Seed Round

May 6, 2026

Total Funding Raised

$1.75M

Company Overview

Mitera Biosciences is a biotechnology company that develops investigational therapeutics for the treatment of autoimmune and alloimmune disorders.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mitera Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mitera Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMay 6, 2026
SeedDec 30, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Kevin Chow

Co-founder, President & CEO

Founding Team

Mitera Biosciences Investors

Notable investors and investment history

InvestorRounds
Cedars Sinai Health VenturesSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 6, 2026

    $1.1M seed round completed.

  • Dec 30, 2025

    $1.75M round led by Cedars Sinai Health Ventures

View all signals

Mitera Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mitera Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mitera Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBellevue, Washington
Employee Range1
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.